The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery
- Conditions
- Colorectal Cancer
- Registration Number
- NCT06508541
- Lead Sponsor
- Shanghai Tong Ren Hospital
- Brief Summary
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 235
(1)age > 18 years, (2)confirmed diagnosis of primary CRC, (3)preoperative tumor stage of cT1 to cT4, N-/+, M0 as determined by contrast-enhanced computed tomography (CT), (4) no distant metastasis, and (5)American Society of Anesthesiologists(ASA)Physical Status Classification score of 1, 2, or 3-
(1) history of previous colorectal surgery, emergent surgery, or palliative resection;(2)pregnancy or breastfeeding;(3) allergy or history of an adverse reaction to ICG; and (4) severe mental disorder.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disease-free survival(DFS) 1 month the duration from radical surgery to the confirmation of recurrence or metastasis by regular or telephone follow-up
- Secondary Outcome Measures
Name Time Method the number of harvested lymph nodes 1month the number of harvested lymph nodes including positive and negative ones
Trial Locations
- Locations (1)
Shanghai Tongren Hospital
🇨🇳Changning, Shanghai, China
Shanghai Tongren Hospital🇨🇳Changning, Shanghai, China